JP2017530108A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017530108A5 JP2017530108A5 JP2017512822A JP2017512822A JP2017530108A5 JP 2017530108 A5 JP2017530108 A5 JP 2017530108A5 JP 2017512822 A JP2017512822 A JP 2017512822A JP 2017512822 A JP2017512822 A JP 2017512822A JP 2017530108 A5 JP2017530108 A5 JP 2017530108A5
- Authority
- JP
- Japan
- Prior art keywords
- place
- oeg
- mimiline
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14183551 | 2014-09-04 | ||
| EP14183551.2 | 2014-09-04 | ||
| PCT/EP2015/069996 WO2016034604A1 (en) | 2014-09-04 | 2015-09-02 | Novel amylin and calcitonin receptor agonist |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020114038A Division JP7095027B2 (ja) | 2014-09-04 | 2020-07-01 | 新規のアミリン及びカルシトニン受容体アゴニスト |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017530108A JP2017530108A (ja) | 2017-10-12 |
| JP2017530108A5 true JP2017530108A5 (https=) | 2018-10-11 |
| JP6728141B2 JP6728141B2 (ja) | 2020-07-22 |
Family
ID=51483301
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017512822A Active JP6728141B2 (ja) | 2014-09-04 | 2015-09-02 | 新規のアミリン及びカルシトニン受容体アゴニスト |
| JP2020114038A Active JP7095027B2 (ja) | 2014-09-04 | 2020-07-01 | 新規のアミリン及びカルシトニン受容体アゴニスト |
| JP2022100480A Pending JP2022130522A (ja) | 2014-09-04 | 2022-06-22 | 新規のアミリン及びカルシトニン受容体アゴニスト |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020114038A Active JP7095027B2 (ja) | 2014-09-04 | 2020-07-01 | 新規のアミリン及びカルシトニン受容体アゴニスト |
| JP2022100480A Pending JP2022130522A (ja) | 2014-09-04 | 2022-06-22 | 新規のアミリン及びカルシトニン受容体アゴニスト |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9593149B2 (https=) |
| EP (1) | EP3189071B1 (https=) |
| JP (3) | JP6728141B2 (https=) |
| CN (1) | CN106687474A (https=) |
| AR (1) | AR101742A1 (https=) |
| ES (1) | ES2887370T3 (https=) |
| TW (1) | TW201625671A (https=) |
| WO (1) | WO2016034604A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017019378A2 (pt) | 2015-03-18 | 2019-02-19 | Zealand Pharma A/S | análogos de amilina |
| US10071140B2 (en) | 2016-09-09 | 2018-09-11 | Zealand Pharma A/S | Amylin analogues |
| ES2828526T3 (es) | 2016-11-07 | 2021-05-26 | Novo Nordisk As | Esteres activos DCHBS de compuestos PEG y sus usos |
| CN109248323B (zh) * | 2017-07-14 | 2023-09-08 | 杭州先为达生物科技有限公司 | 酰化的glp-1衍生物 |
| US11274158B2 (en) | 2018-01-30 | 2022-03-15 | Flagship Pioneering Innovations V, Inc. | Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators |
| AR116632A1 (es) | 2018-10-11 | 2021-05-26 | Intarcia Therapeutics Inc | Polipéptidos análogos de la amilina humana y sus métodos de uso |
| WO2020180534A1 (en) | 2019-03-01 | 2020-09-10 | President And Fellows Of Harvard College | Methods and compositions for protein delivery |
| CN110467666A (zh) * | 2019-09-17 | 2019-11-19 | 湖北强耀生物科技有限公司 | 一种新型胰岛淀粉样多肽的合成方法 |
| TWI850611B (zh) * | 2020-12-18 | 2024-08-01 | 丹麥商諾佛 儂迪克股份有限公司 | Glp-1及澱粉素受體之共促效劑 |
| AR124295A1 (es) | 2020-12-18 | 2023-03-15 | Lilly Co Eli | Agonistas duales del receptor de amilina y calcitonina y usos de los mismos |
| WO2022248419A2 (en) | 2021-05-22 | 2022-12-01 | Adocia | Compositions comprising short-acting hormones for treating or preventing obesity and pumps comprising said composition |
| EP4144362A1 (en) | 2021-09-06 | 2023-03-08 | Adocia | Compositions comprising short-acting hormones for treating or preventing obesity and pumps comprising said composition |
| EP4129324A1 (en) | 2021-08-02 | 2023-02-08 | Adocia | Compositions comprising at least an amylin receptor agonist and a glp-1 receptor agonist |
| AU2022386166A1 (en) | 2021-11-10 | 2024-06-20 | I2O Therapeutics, Inc. | Ionic liquid compositions |
| CN116621944A (zh) * | 2022-02-10 | 2023-08-22 | 成都奥达生物科技有限公司 | 一种长效肝炎病毒进入抑制剂 |
| JP2025530743A (ja) | 2022-08-29 | 2025-09-17 | イーライ リリー アンド カンパニー | 経口投与のための組成物 |
| US12116388B2 (en) | 2022-12-22 | 2024-10-15 | Novo Nordisk A/S | Amylin receptor agonists |
| TW202540155A (zh) | 2023-11-30 | 2025-10-16 | 丹麥商諾佛 儂迪克股份有限公司 | Glp-1、gip及澱粉素受體之三重促效劑 |
| CN120040558A (zh) * | 2024-03-19 | 2025-05-27 | 深圳湾实验室 | 多肽或其类似物及其应用 |
| WO2025240893A1 (en) | 2024-05-17 | 2025-11-20 | Eli Lilly And Company | 4-phenyl-1h-pyrazolo[3,4-b]pyridine-5-carboxamide derivatives as amylin and/or calcitonin receptor agonists for the treatment of type 2 diabetes, obesity or overweight |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4414149A (en) | 1983-03-04 | 1983-11-08 | Armour Pharmaceutical Company | Glycine8 -D-arginine24 calcitonin |
| US4495097A (en) | 1983-04-04 | 1985-01-22 | Armour Pharmaceutical Company | Des-serine2 -glycine8 calcitonin |
| US4659804A (en) | 1984-11-01 | 1987-04-21 | Armour Pharmaceutical Company | (Bis-1,7-S-acetamidomethyl-L-cysteine)salmon calcitonin |
| US4622386A (en) * | 1985-03-28 | 1986-11-11 | Armour Pharmaceutical Company | [1,7-di-alanine]calcitonin |
| EP0297159A1 (en) * | 1987-07-01 | 1989-01-04 | Armour Pharmaceutical Company | [N-Acyl, 1,7-Di-Aline] calcitonins, method for their preparation, pharmaceutical compositions and use |
| US5153308A (en) | 1988-06-16 | 1992-10-06 | Teijin Limited | S-sulfonated calcitonin derivatives |
| US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
| CN1064051C (zh) | 1997-04-30 | 2001-04-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 不含二硫键的鲑鱼和鳗鱼降钙素类似物及其制备方法 |
| US6087334A (en) * | 1998-08-21 | 2000-07-11 | Amylin Pharmaceuticals, Inc. | Anti-diabetic peptides |
| US8076288B2 (en) * | 2004-02-11 | 2011-12-13 | Amylin Pharmaceuticals, Inc. | Hybrid polypeptides having glucose lowering activity |
| WO2007014051A2 (en) | 2005-07-22 | 2007-02-01 | Amylin Pharmaceuticals, Inc. | Use of amylin and amylin agonists as cardioprotective or myoprotective agents |
| CN102076353A (zh) * | 2008-06-25 | 2011-05-25 | 诺沃-诺迪斯克有限公司 | 胰岛淀粉样多肽和鲑鱼降钙素的衍生杂合肽 |
| ES2622877T3 (es) | 2009-01-22 | 2017-07-07 | Keybioscience Ag | Tratamiento para la obesidad |
| CA2755068C (en) | 2009-03-12 | 2018-11-06 | Keybioscience Ag | Treatment of diabetes and metabolic syndrome |
| PT2621515T (pt) * | 2010-09-28 | 2017-07-12 | Aegerion Pharmaceuticals Inc | Polipéptido quimérico de leptina de foca-ser humano com solubilidade aumentada |
| KR20140045433A (ko) * | 2011-05-25 | 2014-04-16 | 아밀린 파마슈티칼스, 엘엘씨. | 아밀린 펩티드 및 그의 유도체 및 용도 |
| JP6121992B2 (ja) * | 2011-06-10 | 2017-04-26 | ノヴォ ノルディスク アー／エス | ポリペプチド |
-
2015
- 2015-09-02 WO PCT/EP2015/069996 patent/WO2016034604A1/en not_active Ceased
- 2015-09-02 TW TW104128938A patent/TW201625671A/zh unknown
- 2015-09-02 CN CN201580046850.8A patent/CN106687474A/zh active Pending
- 2015-09-02 JP JP2017512822A patent/JP6728141B2/ja active Active
- 2015-09-02 ES ES15766071T patent/ES2887370T3/es active Active
- 2015-09-02 EP EP15766071.3A patent/EP3189071B1/en active Active
- 2015-09-02 AR ARP150102805A patent/AR101742A1/es unknown
-
2016
- 2016-05-10 US US15/151,093 patent/US9593149B2/en active Active
-
2017
- 2017-01-27 US US15/417,671 patent/US10174082B2/en active Active
-
2020
- 2020-07-01 JP JP2020114038A patent/JP7095027B2/ja active Active
-
2022
- 2022-06-22 JP JP2022100480A patent/JP2022130522A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017530108A5 (https=) | ||
| JP2015514395A5 (https=) | ||
| NZ740644A (en) | Glucagon receptor agonists | |
| PE20200926A1 (es) | Peptidos analogos de incretina | |
| RU2021134101A (ru) | Модифицированная j-цепь | |
| JP2014525439A5 (https=) | ||
| EA201170305A1 (ru) | Аналоги глюкозозависимого инсулинотропного полипептида (gip), модифицированные по n-концу | |
| JP2014224126A5 (https=) | ||
| JP2014501510A5 (https=) | ||
| NZ715038A (en) | T cell receptors | |
| NZ593833A (en) | Extended recombinant polypeptides and compositions comprising same | |
| JP2015038108A5 (https=) | ||
| JP2007045829A5 (https=) | ||
| HRP20191614T1 (hr) | Spojevi koji su suagonisti gip i glp-1 | |
| JP2017528419A5 (https=) | ||
| RU2015146614A (ru) | Конъюгированная вакцина на основе пептида антигена wt1 | |
| MX2017016101A (es) | Polinucleotidos y polipetidos de adenovirus. | |
| RU2018137842A (ru) | Агонисты рецепторов глюкагона/glp-1 для лечения ожирения | |
| JP2014000092A5 (https=) | ||
| EA200870237A1 (ru) | Последовательности пептидов и композиции | |
| JP2010065037A5 (https=) | ||
| JP2015516983A5 (https=) | ||
| ES2531288T3 (es) | Proteína de fusión anticancerígena | |
| WO2009087081A3 (de) | Neue insulinderivate mit extrem verzögertem zeit-/wirkungsprofil | |
| PH12018502465A1 (en) | Mic-1 compounds and use thereof |